Brandon How
Reporter
Brandon is a breaking news reporter for Capital Brief, based in Sydney. He previously spent three years as a tech policy and innovation reporter for InnovationAus.com in Perth and the federal press gallery in Canberra. His byline has also appeared in Business News.
Contact Brandon via email.
After three weeks in court, Mayne Pharma and Cosette Pharmaceuticals await a ruling that could decide their $672m deal’s fate, with FIRB approval still pending.
Fixed income investors may have an opportunity to lock in attractive yields amid growing expectations the RBA's next rate cut may be delayed until next year.